186 related articles for article (PubMed ID: 7714761)
21. Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms.
Sogo N; Magid KS; Shaw CA; Webb DJ; Megson IL
Biochem Biophys Res Commun; 2000 Dec; 279(2):412-9. PubMed ID: 11118301
[TBL] [Abstract][Full Text] [Related]
22. Relative potency of nitrovasodilators on human placental vessels from normal and preeclamptic pregnancies.
González C; Cruz MA; Gallardo V; Miguel P; Carrasco G
Gynecol Obstet Invest; 1997; 43(4):219-24. PubMed ID: 9194618
[TBL] [Abstract][Full Text] [Related]
23. The relaxation induced by S-nitroso-glutathione and S-nitroso-N-acetylcysteine in rat aorta is not related to nitric oxide production.
Ceron PI; Cremonez DC; Bendhack LM; Tedesco AC
J Pharmacol Exp Ther; 2001 Aug; 298(2):686-94. PubMed ID: 11454932
[TBL] [Abstract][Full Text] [Related]
24. Superoxide does not inhibit glyceryl trinitrate-rabbit aortic strip-mediated relaxation of rabbit Taenia coli. Evidence against a role for nitric oxide itself as the smooth muscle active drug metabolite?
Hussain AS; Brien JF; Marks GS; Nakatsu K
Drug Metab Dispos; 1996 Jul; 24(7):780-5. PubMed ID: 8818576
[TBL] [Abstract][Full Text] [Related]
25. Induction of heme oxygenase-1 as a response in sensing the signals evoked by distinct nitric oxide donors.
Hara E; Takahashi K; Takeda K; Nakayama M; Yoshizawa M; Fujita H; Shirato K; Shibahara S
Biochem Pharmacol; 1999 Jul; 58(2):227-36. PubMed ID: 10423162
[TBL] [Abstract][Full Text] [Related]
26. Nitroxyl: a vasodilator of human vessels that is not susceptible to tolerance.
Andrews KL; Lumsden NG; Farry J; Jefferis AM; Kemp-Harper BK; Chin-Dusting JP
Clin Sci (Lond); 2015 Jul; 129(2):179-87. PubMed ID: 25728899
[TBL] [Abstract][Full Text] [Related]
27. Rapid and irreversible inactivation of protein tyrosine phosphatases PTP1B, CD45, and LAR by peroxynitrite.
Takakura K; Beckman JS; MacMillan-Crow LA; Crow JP
Arch Biochem Biophys; 1999 Sep; 369(2):197-207. PubMed ID: 10486138
[TBL] [Abstract][Full Text] [Related]
28. Stimulatory and inhibitory action of nitric oxide donor agents vs. nitrovasodilators on reactive oxygen production by isolated polymorphonuclear leukocytes.
Pieper GM; Clarke GA; Gross GJ
J Pharmacol Exp Ther; 1994 May; 269(2):451-6. PubMed ID: 8182511
[TBL] [Abstract][Full Text] [Related]
29. Effects of oxidizing and reducing agents on ovine pulmonary artery responses to nitric oxide donors, sodium nitroprusside and 3-morpholino-sydnonimine.
Sardar KK; Sarkar SN; Bawankule DU; Mishra SK; Raviprakash V
Indian J Exp Biol; 2006 Dec; 44(12):964-70. PubMed ID: 17176668
[TBL] [Abstract][Full Text] [Related]
30. Tolerance and cross-tolerance between SIN-1 and nitric oxide in bovine coronary arteries.
Kukovetz WR; Holzmann S
J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S40-6. PubMed ID: 2484698
[TBL] [Abstract][Full Text] [Related]
31. Effect of the molsidomine metabolite SIN-1 on coronary arteries and peripheral vessels of sheep with special reference to tolerance and endothelium.
Yousif MH; Yousif F; Thulesius O
Cardiovasc Drugs Ther; 1991 Aug; 5(4):769-73. PubMed ID: 1909561
[TBL] [Abstract][Full Text] [Related]
32. In vivo depletion of free thiols does not account for nitroglycerin-induced tolerance: a thiol-nitrate interaction hypothesis as an alternative explanation for nitroglycerin activity and tolerance.
Haj-Yehia AI; Benet LZ
J Pharmacol Exp Ther; 1996 Sep; 278(3):1296-305. PubMed ID: 8819515
[TBL] [Abstract][Full Text] [Related]
33. In vitro inhibition of human and rat platelets by NO donors, nitrosoglutathione, sodium nitroprusside and SIN-1, through activation of cGMP-independent pathways.
Priora R; Margaritis A; Frosali S; Coppo L; Summa D; Di Giuseppe D; Aldinucci C; Pessina G; Di Stefano A; Di Simplicio P
Pharmacol Res; 2011 Sep; 64(3):289-97. PubMed ID: 21539916
[TBL] [Abstract][Full Text] [Related]
34. Oxidative and adhesive responses of human neutrophils to nitrovasodilators in vitro: the role of protein kinases.
Klink M; Tchorzewski H; Sulowska Z
Mediators Inflamm; 2003 Dec; 12(6):345-53. PubMed ID: 14668094
[TBL] [Abstract][Full Text] [Related]
35. Nitric oxide inhibits vascular bioactivation of glyceryl trinitrate: a novel mechanism to explain preferential venodilation of organic nitrates.
Kojda G; Patzner M; Hacker A; Noack E
Mol Pharmacol; 1998 Mar; 53(3):547-54. PubMed ID: 9495823
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of clotting factor XIII activity by nitric oxide.
Catani MV; Bernassola F; Rossi A; Melino G
Biochem Biophys Res Commun; 1998 Aug; 249(1):275-8. PubMed ID: 9705871
[TBL] [Abstract][Full Text] [Related]
37. Glyceryl trinitrate-induced vasodilation is inhibited by ultraviolet irradiation despite enhanced nitric oxide generation: evidence for formation of a nitric oxide conjugate.
Hussain AS; Crispino NH; McLaughlin BE; Brien JF; Marks GS; Nakatsu K
J Pharmacol Exp Ther; 1999 May; 289(2):895-900. PubMed ID: 10215668
[TBL] [Abstract][Full Text] [Related]
38. Chemical evaluation of compounds as nitric oxide or peroxynitrite donors using the reactions with serotonin.
Blanchard B; Servy C; Ducrocq C
Free Radic Res; 2001 Feb; 34(2):189-91. PubMed ID: 11264894
[TBL] [Abstract][Full Text] [Related]
39. Modulation of the pharmacological actions of nitrovasodilators by methylene blue and pyocyanin.
Gryglewski RJ; Zembowicz A; Salvemini D; Taylor GW; Vane JR
Br J Pharmacol; 1992 Aug; 106(4):838-45. PubMed ID: 1327388
[TBL] [Abstract][Full Text] [Related]
40. Effect of nitric oxide on the adhesion of human melanocytes to extracellular matrix components.
Ivanova K; Le Poole IC; Gerzer R; Westerhof W; Das PK
J Pathol; 1997 Dec; 183(4):469-76. PubMed ID: 9496265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
